Making Science Group, S.A. (BME:MAKS)
6.80
0.00 (0.00%)
Jul 17, 2026, 5:24 PM CET
Making Science Group Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 29.7 | 19.81 | 19.54 | 31.35 | 30.22 |
Short-Term Investments | 4.74 | 2.28 | 0.45 | 0.34 | 1.06 |
Cash & Short-Term Investments | 34.44 | 22.1 | 19.99 | 31.69 | 31.28 |
Cash Growth | 55.83% | 10.52% | -36.90% | 1.30% | 153.20% |
Accounts Receivable | 70.27 | 65.9 | 46.12 | 41.31 | 27.7 |
Other Receivables | - | - | - | 4.03 | 2.04 |
Total Trade Receivables | 70.27 | 65.9 | 46.12 | 45.34 | 29.74 |
Inventory | 3.35 | 2.77 | 3.03 | 3.29 | 1.93 |
Other Current Assets | 1.11 | 1.8 | 0.93 | 0.97 | 0.57 |
Total Current Assets | 109.17 | 92.57 | 70.08 | 81.29 | 63.53 |
Net Property, Plant & Equipment | 6.49 | 9.97 | 12.25 | 1.99 | 1.07 |
Other Intangible Assets | 64.21 | 66.09 | 64.11 | 7.04 | 6.35 |
Goodwill | - | - | - | 41.79 | 33.36 |
Long-Term Investments | 1.77 | 1.81 | 1.42 | 1.35 | 1.17 |
Other Long-Term Assets | 1.64 | 2.16 | 2.63 | - | 0 |
Total Assets | 183.28 | 172.61 | 150.48 | 133.47 | 105.47 |
Accounts Payable | 89.27 | 75.97 | 60.96 | 86.08 | 39.84 |
Accrued Expenses | - | - | - | 1.16 | 0.82 |
Short-Term Debt | - | - | 43.85 | 44.64 | 35.56 |
Current Portion of Long-Term Debt | 38.15 | 46.69 | - | - | - |
Current Portion of Leases | - | - | - | - | 0.01 |
Unearned Revenue | - | - | - | 1.14 | 0.32 |
Other Current Liabilities | 2.17 | 0.52 | 0.76 | 27.69 | 31.66 |
Total Current Liabilities | 129.59 | 123.17 | 105.57 | 86.45 | 59.12 |
Long-Term Debt | 7.94 | 15.96 | 25.99 | 57.49 | 64.02 |
Other Long-Term Liabilities | 1.28 | 2.81 | 3.33 | 0.16 | 0.47 |
Total Long-Term Liabilities | 9.21 | 18.77 | 29.32 | 32.37 | 34.54 |
Total Liabilities | 138.8 | 141.94 | 134.89 | 118.82 | 93.66 |
Common Stock | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 |
Treasury Stock | -0 | -0 | -0 | -0 | -0 |
Additional Paid-in Capital | 31.45 | 30.45 | 26.15 | 23.43 | 14.13 |
Accumulated Other Comprehensive Income | 1.52 | 1.76 | 1.4 | 3.76 | -0.8 |
Retained Earnings | 5.26 | -6.55 | -12.22 | -11.64 | -3.31 |
Total Common Shareholders' Equity | 38.33 | 25.75 | 15.42 | 15.63 | 10.11 |
Minority Interest | 6.15 | 4.91 | 0.17 | 0.89 | 1.31 |
Shareholders' Equity | 44.48 | 30.66 | 15.59 | 14.64 | 11.81 |
Total Liabilities & Equity | 183.28 | 172.61 | 150.48 | 133.47 | 105.47 |
Total Debt | 46.09 | 62.65 | 69.83 | 102.12 | 99.59 |
Net Cash (Debt) | -11.65 | -40.55 | -49.84 | -70.44 | -68.31 |
Net Cash Per Share | -1.29 | -4.67 | -5.97 | -8.70 | -8.76 |
Book Value | 38.33 | 25.75 | 15.42 | 15.63 | 10.11 |
Book Value Per Share | 4.24 | 2.97 | 1.85 | 1.93 | 1.30 |
Tangible Book Value | -25.89 | -40.34 | -48.69 | -33.2 | -29.6 |
Tangible Book Value Per Share | -2.87 | -4.65 | -5.83 | -4.10 | -3.79 |